These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37321047)

  • 1. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
    Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
    Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches.
    Auvin S; Arzimanoglou A; Falip M; Striano P; Cross JH
    Epilepsia Open; 2024 Dec; ():. PubMed ID: 39700524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
    Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S
    Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2021 Jan; 35(1):61-83. PubMed ID: 33479851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cenobamate add-on therapy for drug-resistant focal epilepsy.
    Brigo F; Lattanzi S
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014941. PubMed ID: 39087564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of illness in Lennox-Gastaut syndrome: a systematic literature review.
    Strzelczyk A; Zuberi SM; Striano P; Rosenow F; Schubert-Bast S
    Orphanet J Rare Dis; 2023 Mar; 18(1):42. PubMed ID: 36859290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of Lennox-Gastaut Syndrome With Different Subtypes of Tonic Seizures: A Single-Center Retrospective Cohort Study.
    Wang S; Zhao X; Li T; Jia Y; Zhang L; Qi X; Lin Y; Wang Y
    Pediatr Neurol; 2024 Dec; 161():132-138. PubMed ID: 39378606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the patient needs and tolerability of Clobazam liquid formulation (Likozam® 1 mg/mL): A French patient and care-givers' centered survey.
    Scorrano G; Delattre C; Leiber AE; Nabbout R
    Epilepsy Behav; 2024 Dec; 163():110183. PubMed ID: 39662323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Burden of Lennox-Gastaut Syndrome: Implications for Patients, Caregivers, and Society in High and Low Resource Settings: A Narrative Review.
    Mourid MR; Oduoye MO
    Health Sci Rep; 2024 Dec; 7(12):e70169. PubMed ID: 39669191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review.
    Strafella R; Wang R; Petchpradub M; Sacknovitz A; McGoldrick PE; Wolf SM
    Epilepsy Behav Rep; 2024; 28():100730. PubMed ID: 39691187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory interventions for focal epilepsy.
    Panebianco M; Walker L; Marson AG
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD009945. PubMed ID: 37842826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD001909. PubMed ID: 38078494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systematic review.
    Specchio N; Auvin S; Strzelczyk A; Brigo F; Villanueva V; Trinka E
    Epilepsia Open; 2024 Dec; 9(6):2017-2036. PubMed ID: 39360600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perampanel add-on for drug-resistant focal epilepsy.
    Bresnahan R; Hill RA; Wang J
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010961. PubMed ID: 37059702
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.